Patent · US Active

Compositions comprising anakinra

US11324807B2 · kind B2 · utility

0Cited by
1References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2016
Grant dateMay 10, 2022
Priority date
Expiry dateAug 28, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising anakinra, buffer, and optionally at least one osmolyte and optionally further excipients. Further, the present invention relates to use of said compositions for treatment of for example ophthalmic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.